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ABSTRACT
Cell-based therapies are becoming increasingly prominent in numerous medical contexts, 
particularly in regenerative medicine and the treatment of cancer. However, since the efficacy of 
the therapy is largely dependent on the concentration of therapeutic cells at the treatment area, a 
major challenge associated with cell-based therapies is the ability to move and localize therapeutic 
cells within the body. In this Article, a technique based on dynamically programmable magnetic 
fields (DPMF) is successfully demonstrated to non-invasively aggregate therapeutic cells at a 
desired location. Various types of immune cells (neural stem cells, monocytes/macrophages, and 
CAR T-cells) are loaded with iron-oxide nanoparticles and then focused at a particular site using 
externally controlled electromagnets. These experimental results serve as a readily scalable 
prototype for the design of apparatuses that patients can wear which focus therapeutic cells at the 
anatomical sites needed for treatment.
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INTRODUCTION
In recent years, there has been an increased interest in cell-based therapies. From 
regenerative medicine utilizing stem cells such as neural stem cells (NSCs) to cancer therapy 
utilizing chimeric antigen receptor (CAR) T-cells and macrophages, cell-based therapies are an 
expanding part of the therapeutic approach to a number of diseases.1-9 A common theme among 
this diverse repertoire of cell therapies is the importance of localization. Whether trying to heal an 
infarct site or treat a brain tumor, the efficacy of the therapy is largely dependent on the ability of 
the cell product to reach and be retained at a specific anatomical site. Currently, this site-specific 
localization is generally achieved by a local injection or by relying on cell-intrinsic homing 
mechanisms.4, 10, 11 However, these localization strategies are inefficient, and typically only a 
portion of the injected cell product is retained at the desired tissue site.10, 11 Therefore, strategies 
that exert additional external control over cell localization could improve the efficacy of cell-based 
therapies.
Magnetic targeting is an emerging strategy for controlling cell localization. This general 
approach has been used in a number of applications and has been shown to alter cell localization 
both in vitro and in vivo without affecting cell viability.12-21 For nearly all magnetic targeting 
studies, cells are loaded ex vivo with superparamagnetic iron oxide nanoparticles (IONPs) in order 
to make them responsive to magnetic fields. A number of different IONP formulations have been 
used for magnetic targeting studies, with no clear consensus on what types of particles are best and 
few head-to-head comparisons between different formulations.16 Despite this variability in the 
types of IONPs used, these formulations are typically internalized inside the cells to achieve 
effective magnetic targeting. 
The vast majority of previous studies, including our previous work on iron oxide-loaded 
immune cells,17 have employed permanent magnets to direct cell accumulation.13 This approach 
has clear drawbacks for focusing the accumulation of cells at a position within the body. A primary 
challenge is that no energetic minimums can exist in a volume containing no magnetic elements—
this is known as Earnshaw’s Theorem.22 Therefore, magnetic material cannot be localized to a 
fixed position in the body using static external magnets. Implanted magnets create minimum 
energy wells at the target site but are invasive.
However, Earnshaw’s theorem only applies to static magnetic fields. Using dynamically 
changing magnetic fields, energetic minimums can be obtained. Thus, work in this area has 
focused on using electromagnets which can easily create adjustable fields, but typically have lower 
fields due to power and cooling requirements. Programmable magnetic resonance imaging (MRI) 
using open-loop control for fine movement is one approach that has shown proof-of-principle, 
although this solution requires a customized MRI instrument and would likely be prohibitively 
expensive for the days-long timescale expected to be necessary for cell localization in humans. 
Rapidly pulsing strong electromagnets have also shown promise for targeting nanoparticle 
accumulation to a focal point in their center.23 While this work illustrated the potential of this 
approach, it is uncertain if it could be extended to iron oxide-loaded cells as rapid magnetic field 
pulsing is known to cause iron oxide nanoparticles to heat their local environment.24 Indeed, this 
strategy is being actively pursued for cancer therapy where the iron nanoparticles are localized to 
tumors and then a rapidly alternating magnetic field is applied.25 In addition, given the size of the 
magnets used in this work, it is difficult to envision how this system could be applied to a multi-
day application in humans.
Ideally, patients could be equipped with a wearable device that allows for programmable 
magnetic control over the course of days, and the fields applied would be non-toxic to the loaded 
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cells. Here we demonstrate an initial prototype of the key component to such a system: a 
miniaturized, flexible chip that allows for fine control of magnetically loaded cells using 
dynamically programmable magnetic fields (DPMF). This prototype has an active area of 16 mm2, 
consisting of a flexible polymer with 8 individually controllable wires in both the horizontal and 
vertical directions overlapping in an electronic mesh grid. Because each wire is individually 
addressable, this system allows for millions of unique settings from which to generate unique fields 
and forces. Here, we demonstrate that in vitro this system can control the 2D accumulation at 
resolutions below 300 µm with no toxicity to the cells. The location of accumulation can be 
switched multiple times. This was demonstrated using three different cells types currently used in 
cell therapies: neural stem cells (NSCs), monocytes (THP-1), and chimeric antigen receptor (CAR) 
T-cells. In order to optimally load these cells with iron nanoparticles, two different coatings were 
used—NSCs and THP-1 cells endocytosed PEGylated iron-oxide nanoparticles, but CAR T-cells 
did not and instead were loaded by using silica-coated IONPs that stuck to the cell membrane. 
While the DPMF prototype is quite small, the device is passively cooled and the design can be 
directly scaled to larger areas. To the best of our knowledge, this work is the first to demonstrate 
a miniaturized device capable of rapidly programmable magnetic control of human cell movement.
RESULTS AND DISCUSSION
We previously developed an apparatus that allows for live cell imaging while a magnetic 
field is applied and used it to show that when immune cells are loaded with immunostimulatory 
IONPs the cells can be accumulated by applying a fixed permanent magnet.17, 26 Here we used this 
system to evaluate our DPMF chip. The cell-box apparatus consists of a disposable, 3D-printable 
chassis that fits in a 100 mm petri dish (Figure 1a). A coverslip is affixed to the central region of 
the chassis and the DPMF chip is inserted to be flush against the backside of the coverslip. The 
assembled apparatus is then placed in a petri dish containing IONP-loaded cells and cell media. 
The chassis contains atmosphere distribution channels that allow for atmospheric regulation of the 
cell media and risers that keep the coverslip suspended just above the bottom of the petri dish. 
The DPMF system is capable of over 1 million unique magnetic profiles within a 16 mm2 
active area.17, 26 Controller circuitry (Figure 1b) is housed separately and electrically connects to 
the active area. The active area is passively cooled via a copper heatsink behind the active area. 
The active area is thermally connected to the copper attachment using thermal paste. As a 
demonstration of the aggregating ability of system, magnetic particles are moved to two different 
locations (Figure 1c). The particles (Bangs Laboratories, Indiana, USA) are magnetic 
microspheres large enough for visibility under microscopy (3 µm). The full video can be seen in 
Supplementary Video 1.
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Figure 1. (a) Design of cell-box apparatus for imaging during DPMF. (b) A sample field profile 
for aggregating cells to a single point (left) and schema of the active area of the DPMF chip (right). 
(c) Positive control experiment. Magnetic particles 3 m in diameter are used to verify the 
magnetic aggregation capabilities of the system.
Here, two types of surface modification chemistries (PEGylation by intercalation and 
silica-coating IONPs) were used to convert hydrophobic oleic acid-coated IONPs to hydrophilic, 
biocompatible IONPs prior to loading onto cells (Figure 2a). Following purification by 
centrifugation and washing, successful surface functionalization was confirmed by TEM, DLS, 
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zeta potential, and by the particles being readily dispersible in water (Figure 2b-c). The PEGylated 
particles (DSPE-IONP) showed an increase in hydrodynamic diameter from 30 to 98.2 nm and a 
relatively neutral zeta potential of -3.67, both of which are common for PEGylated particles. The 
Si-IONPs had a hydrodynamic diameter of 160 nm, a zeta potential of -16.56, and a coating visible 
in TEM images.
 
Figure 2. Synthesis and characterization of DSPE-IONPs and Si-IONPs. Synthetic scheme of (a) 
DSPE-PEG-coated IONPs (DSPE-IONPs) and silica-coated IONPs (Si-IONPs). (b) TEM images 
of DSPE-IONPs and Si-IONPs. The scale bars in each image are 100 nm. (c) Table of the diameter, 
polydisperity index (PDI), and zeta potential of DSPE-IONPs and Si-IONPs.
In order to determine what IONP concentrations could be tolerated by cells, each IONP 
formulation was screened for cell toxicity (Figure 3b). Because this is a proof-of-principle study 
focused on the development of DPMF, we were primarily concerned about ensuring that the cells 
remained intact (e.g., minimal necrosis and cell debris) during the course of the in vitro 
experiments. Thus, the cells were evaluated for acute toxicity after 1 h of incubation with the 
IONPs. In general, it was found that doses at or above 45 µg were toxic to cells. 
To confirm internalization of the IONPs, cells were incubated with 10 µg and loading was 
evaluated by TEM imaging (Figure 3a, Supplementary Figure 1). The Si-IONPs are readily 
identified by their distinctive fish-egg like structure with the dark iron core and lighter silica 
coating (Supplementary Figure 1a-e). However, the DSPE-NPs are more challenging to identify 
as they only possess a dark iron core and transparent polymer coating, so they are most readily 
identified as dark aggregates of unusual shape (Supplementary Figure 1f-i). It was found that the 
NSCs and THP-1 cells readily endocytosed IONPs (especially DSPE-IONPs) but the CAR T-cells 
did not show any IONP internalization. Surprisingly, despite this lack of IONP internalization, it 
was found in preliminary experiments that the Si-IONP-loaded CAR T-cells were in fact 
magnetized, demonstrating that the Si-IONPs were associated with the CAR T-cells in some way 
(Supplementary Video 4). A closer examination of the TEM images consistently showed Si-
IONPs aggregated in close proximity to the cell surface of CAR T-cells even after washing steps 
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to remove free particles, possibly suggesting some sort of non-specific association with the cell 
surface similar to the observations of Sanz-Ortega et al.9 However, the precise mechanism of Si-
IONP association with CAR T-cells is not known and will need to be thoroughly investigated 
before any therapeutic application. For the purposes of this proof-of-principle study of DPMF, 
though, we were satisfied with simply obtaining magnetized cells.
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Figure 3. (a) TEM imaging of loaded cells. Cellular uptake and non-specific binding of Si-IONPs 
and DSPE-IONPs in cells. TEM images of Si-IONPs and DSPE-IONPs (IONPs with 10 µg of Fe 
content) labeled THP-1 cells, NSCs, and CAR T-cells. All scale bars are 1 µm. See Supplementary 
Figure 1 for additional TEM images of loaded cells. (b) Cell viability after loading with DSPE-
IONP or Si-IONP. 
Having identified the preferred IONP for loading each cell type, we proceeded to evaluate 
the ability of our DPMF chip to control the accumulation of the cells. For each cell type, the DPMF 
chip was initially programmed to target cells at one point (represented by the red dot in the box 
over the first arrows in Figure 4) and then after cells had accumulated at that position the chip was 
reprogrammed to target a second location (represented by the red dot in the box over the second 
arrows in Figure 4). Video was recorded for the entire duration of movement for each experiment 
(Supplementary Videos 2-4); only a representative sample of individual frames is presented in 
Figure 4. In the supplementary videos, it can be seen that the cells immediately change their 
trajectory when the target location is switched. It is evident from these observations as well as the 
positive control experiment involving the beads alone that the movement of the loaded cells is due 
to the magnetic field. To control for other non-magnetic causes of cell movement, cells alone (no 
IONP-loading) were exposed to the same DPMF focusing conditions. These negative controls 
showed no coordinated cell movement (data not collected). To serve as further validation, however, 
another negative control experiment showing no movement of loaded cells in the absence of a 
magnetic field is also provided for reference (Supplementary Video 5). 
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Figure 4. Magnetic movement of fluorescent cells controlled by DPMF. Each cell type is localized 
to an initial position, and then traversed to a secondary position. The localization positions are 
roughly indicated by the red dots. The final position of aggregation was deliberately changed 
during each experiment to showcase aggregation flexibility. (a) Magnetic movement of NSCs 
loaded with 0.5 µg of DSPE-IONPs. (b) Magnetic movement of THP-1 cells loaded with 0.5 µg 
of DSPE-IONPs. (c) Magnetic movement of CAR T-cells loaded with 30 µg of Si-IONPs. The 
cells are made fluorescent in the green channel by staining with CellTrace CFSE dye. The numbers 
in the top left corner of each image are the time stamps for that frame (mm:ss). To view the full 
original videos, see Supplementary Videos 2, 3, and 4, respectively.
An image processing algorithm was used to track cellular speeds during the DPMF 
experiments (Figure 5). Due to random variations in spatial distributions of cells, there is a large 
variation in the number of cells tracked for speed calculations. A total of 120 CAR T-cells, 390 
THP-1 monocytes, and 230 NSCs were tracked. In general, cellular speed decreases as the cell 
moves closer to the aggregation point, as the magnetic force’s in-plane (i.e., aggregating) 
component becomes weaker while its normal component becomes stronger. Reduction of speed 
also occurs because of cellular crowding. Note that there is more speed variability at farther radial 
distances due to the fact that the cells start from rest. Speeds of up to around 4.5 µm/sec were 
recorded at distances less than a millimeter away. On average, CAR T-cells tended to be the fastest, 
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whereas THP-1 cells exhibited the slowest movement. A two-sample unequal variances t-test was 
employed to establish the statistical significance of the observed deviations between the speeds of 
different cell types.27, 28 Specifically, with a p-value not exceeding 0.05, both CAR T-cells and 
NSCs aggregated toward the center at least twice (or, more precisely, 2.2 times) as fast as the THP-
1 cells did. Furthermore, at radial distances of 400 µm or greater, a comparison of CAR T-cells 
and NSCs revealed (again at a 5% significance level) that the average aggregation speeds of the 
CAR T-cells were higher by at least 18% or 0.4 µm/sec. On the other hand, note that differences 
in movement speeds among cells of the same type could be related to their hydrodynamic or 
adherent properties and/or variation in magnetic bead uptake. Overall, it was found that the 
movement of all three cell types loaded with two different IONP formulations could be readily 
controlled using the DPMF chip.
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Figure 5. Cell tracking during DPMF. Cell trajectory contours (yellow lines) overlaid on a 
snapshot of the videos for (a) NSCs loaded with 0.5 µg of DSPE-IONPs, (b) THP-1 cells loaded 
with 0.5 µg of DSPE-IONPs, and (c) CAR T-cells loaded with 30 µg of Si-IONPs. The cells 
identified by the tracking algorithm are circled, where brighter colored circles indicate more 
clearly identified cells. In order to ensure a low false-positive rate for the tracking algorithm, not 
all cells in the video were successfully identified by the algorithm. (d) Average speeds of the 
tracked cells within a set of radial distance intervals (±10 µm of the axis labels). The error bars 
represent 95% confidence intervals for the average speeds. (The error bars for the THP-1 cells are 
barely noticeable.) (e) Distribution of speeds at a radial distance of 450 µm. Note that the speed-
axis labels represent the upper limits of the bins.
CONCLUSION
We have demonstrated a prototype for DPMF-controlled cell movement. The current 
system is a miniature programmable electronic grid that can be rapidly reprogrammed in real time. 
We identified surface coatings for IONPs that facilitated loading of three different cell types used 
in cell therapies: stem cells (NSCs), macrophages (THP-1), and CAR T-cells. All of the loaded 
cells were readily controlled using the DPMF system, and this was visualized using our custom 
designed apparatus. While the current prototype is quite small and would not be used for human 
applications, the design can be directly scaled to larger formats to cover a sufficient therapeutic 
area. In addition, it is recognized that the forces exerted by the prototype are much too small to be 
effective in humans. However, the strength of the system will be dramatically boosted in future 
iterations by incorporating magnetizable materials that amplify the power of the programmable 
elements. The ability of DPMF to direct cell accumulation to an interior focal point combined with 
DPMF’s inherent ability to be rapidly adjusted makes it a good candidate for applications in 
internal targeting for patients. In addition to creating a true aggregation point, DPMF may allow 
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for control of delivery paths throughout the body by adjusting fields to route particles along a 
desired trajectory.
MATERIALS AND METHODS
Instrumentation
Dynamic light scattering (DLS) and zeta potential (ZP) measurements were performed on 
a Brookhaven 90 Plus/BI-MAS Instrument (Brookhaven Instruments, New York). DLS 
measurements were obtained by performing 5 runs at 30 s per run and the ZP values by measuring 
10 runs involving 20 cycles per run. All nanoparticle solutions were filtered through a 0.45 μm 
cellulose filter prior to performing DLS and ZP measurements.
Transmission electron microscopy (TEM) images were obtained with a with an FEI Tecnai 
T12 transmission electron microscope at an accelerating voltage of 120 keV and images were taken 
with a Gatan Ultrascan 2K CCD camera. NPs dispersed in water at an optimal concentration were 
drop cast onto glow-discharged, 300-mesh carbon/formvar coated grids and allowed to dry before 
imaging.
Materials
All organic and inorganic compounds (except PEG compounds) were purchased from 
Sigma Aldrich. 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[methoxy(polyethyleneglycol)-2000] (ammonium salt) (DSPE-PEG2000) was purchased from 
Avanti Polar Lipids, Inc. (Catalogue #880120P). Super paramagnetic iron oxide nanoparticles 
suspended in chloroform (d = 30 nm, catalogue #SOR-30-50) were purchased from Ocean 
Nanotech, Springdale, AR, USA. 
Cell Culture
All cells were cultured and maintained at 37°C in a humidified incubator (Thermo Electron 
Corporation, CA, USA) containing 5% CO2. Neural stem cells were cultured in Dulbecco’s 
Modifed Eagle’s Medium (DMEM; Invitrogen, CA, USA) supplemented with 10% fetal bovine 
serum (Gemini Bio, CA, USA), 1% L-glutamine (Invitrogen) and 1% penicillin–streptomycin 
(Invitrogen). When the cells reached 80% confluency, they were passaged using a 0.25% 
trypsin/ethylenediaminetetraacetic acid solution (Invitrogen); media was changed every 2-3 days. 
THP-1 cells were cultured in RPMI 1640 medium (ATCC, USA) supplemented with 50 μM of β-
mercaptoethanol, 10% fetal bovine serum (Gemini Bio, CA, USA), 1% L-glutamine (Invitrogen) 
and 1% penicillin–streptomycin (Invitrogen). THP-1 cell cultures were maintained at 2-8×105 
viable cells/mL density by the addition of fresh medium or replacement of medium. CAR T-cells 
were obtained from Christine Brown (City of Hope, CA). Briefly, central memory subsets of CD3 
T-cells were enriched and then transduced by lentivirus with an interleukin-13 (E13Y-mutated) 
ligand-based CAR, containing a 4-1BB costimulatory domain (IL13BBζ), and truncated CD19 
(CD19t) as a marker for transduction efficiency. CAR T-cells were cultured in X-VIVO 15 
medium supplemented with 10% fetal bovine serum (Gemini Bio, CA, USA). Cytokines IL2 and 
IL15 were added into cell culture three times a week. 
Synthesis of DSPE-PEG coated Iron Oxide Nanoparticles (IONPs)
In a 20 mL scintillation vial, 1 mg of IONPs (40 μL, 25 mg/mL Fe) suspended in 
chloroform was added into 200 μL of chloroform, followed by the addition of excess of DSPE-
PEG2000 (DSPE:IONP = 30:1 by weight) in 800 μL of chloroform. While the mixture was being 
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stirred at room temperature, DMSO (4 mL) was added into chloroform slowly, subsequently the 
mixture was shaken on a nutator for another 30 min. After chloroform being removed by reduced 
pressure, MilliQ water (16 mL) was added to the DMSO mixture dropwise to disperse the DSPE-
PEG coated IONPs. DSPE-IONPs were washed with MilliQ water three times by centrifugation 
using a spin filter with a molecular weight cutoff of 100 kDa (3000 rpm, 1 min) and stored in 
MilliQ water at 4°C.
Synthesis of Silica-coated Iron Oxide Nanoparticles (Si-IONPs)
The preparation of silica-coated IONPs was adapted from the method reported previously 
by Lu et al.29 In a 25-mL round bottom flask, 1 mg of IONPs (40 μL, 25 mg/mL Fe) suspended in 
chloroform was added into a mixture containing 7.7 mL cyclohexane, 2 mL Triton X-100, 1.6 mL 
hexanol, and 0.34 mL MilliQ water. The reaction mixture was stirred vigorously at room 
temperature for 5 min, and subsequently tetraethyl orthosilicate (TEOS, 40 μL) was added. The 
microemulsion system was further stirred at room temperature for 5 h before ammonium hydroxide 
(100 μL) was added to initiate the TEOS hydrolysis reaction. After stirring the reaction at room 
temperature for 24 h, the entire mixture was transferred to a 50 mL conical tube before being 
quenched with absolute ethanol (40 mL). Si-IONPs were collected by centrifugation (4000 rpm, 
20 min) and washed three times by absolute ethanol with vortexing and sonication in between 
washes to help the NPs disperse back into solution.
Sample Preparation for Transmission Electron Microscopy (TEM)
Transmission electron microscopy (TEM) was performed on an FEI Tecnai 12 
transmission electron microscope equipped with a Gatan Ultrascan 2K CCD camera. Cells labeled 
with DSPE-IONPs or SiIONPs described previously were collected by centrifugation, and washed 
once with PBS (500 g, 4 min). Cell pellets were then resuspended in fixative (2% glutaraldehyte 
in 0.1M Cacodylate buffer (Na(CH3)2AsO2 ·3H2O), pH 7.2, at 4°C) overnight. The following day, 
cell pellets were washed three times with 0.1M Cacodylate buffer at pH 7.2, post-fixed with 1% 
OsO4 in 0.1M Cacodylate buffer for 30 min, and washed three times with 0.1M Cacodylate buffer. 
The samples were then dehydrated step-wise via solvent exchange with 60%, 70%, 80%, 95% 
ethanol, 100% absolute ethanol (twice), propylene oxide (twice), and were left in propylene 
oxide/Eponate (1:1) overnight at room temperature in a sealed environment. The following day 
the vials were left opened at room temperature (~2-3 h) to allow propylene oxide to evaporate. The 
samples were then embedded in 100% Eponate with polymerization at ~64°C for 48 hours. Ultra-
thin cell-containing sections (~70 nm thick) were cut using a Leica Ultra cut UCT ultramicrotome 
with a diamond knife, picked up on 200 mesh copper EM grids. Grids were stained with 2% uranyl 
acetate for 10 minutes followed Reynold’s lead citrate staining for 1 minute.
In Vitro Cell Viability Assay by Flow Cytometry
THP-1 cells and NSCs were labeled with six doses of DSPE-IONPs and SI-IONPs cells 
containing 0.5, 2.5, 5, 15, 45, and 75 μg of Fe using the cell labeling method described above. 
After their exposure to various amount of IONPs for 1 h at 37°C, cells were washed once with 
PBS to remove unbound NPs, followed by staining with 1 mL of PBS containing 3 μM of 
propidium iodide for 15 min at room temperature. Their viability was then measured by flow 
cytometry. 
Cell Box-Induced Cell Movement Captured by Live Cell Imaging
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The cell box assembly was previously described by White et al.17 Briefly, a large cover 
slip was attached onto the opening of a sterilized cell box using a non-cytotoxic silicone-based 
adhesive (Sibione Med Adhesive 4100 RTV, Factor II, Catalogue #A-4100). The adhesive was 
allowed to cure for 48 h at room temperature in a sterile environment (BS Level II hood). On the 
day of the cell box-induced cell movement experiments, THP-1 cells (1×107 cells) were cultured 
as described previously and labeled with DSPE-IONPs (0.5 μg of Fe per 1×106 NSC or THP-1 
cells) or Si-IONPs (30 µg per 1×106 CAR T-cells) for 1 h at 37°C. The cells were also fluorescently 
labeled with CellTrace CFSE (per the manufacturer’s instructions). After the exposure to IONPs, 
cells were washed once with PBS to remove unbound NPs before they were resuspended in full 
RPMI 1640 medium (10 mL) and transferred to a petri dish with a diameter of 100 mm. The box-
coverslip assembly was inverted and submerged into the petri dish containing IONP-labeled cells 
in media. The experimental set up was enclosed in a glass chamber with regulated CO2 level (5%). 
Live cell imaging was performed on a Zeiss Axio Observer Z1 inverted microscope with the 
Pecon/Zeiss incubation system. The camera and the microscope were controlled by the Zen Blue 
software. A bright-field picture was taken to indicate the initial location of the cells in solution 
under the view of the microscope after the cell box was set up on the microscope. The electric 
current in the wires in the magnetic grid was switched on to generate a magnetic field. 
Simultaneously, a video in the bright field channel was started to record the movement of the 
IONP-labeled cells in media under the cell box. 
Dynamically-Programmable Magnetic Field (DPMF) Device
The DPMF apparatus (Figure 6) comprises three components: a controller, an inverted 
microscope, and a cell box. The controller is interfaced through a computer. The first system is a 
controller used to generate a particular magnetic field profile. The controller consists of a computer 
interface to a custom printed circuit board (PCB) constructed using a standard FR4 two-layer 
board. The PCB simultaneously controls 8 electromagnetic channels, each with a 16-bit current 
resolution and reversible polarity. A DAQ digital-to-analog converter (National Instruments, 
USA) is used to program voltage biases to the controller. Using a custom-developed software 
package, commands are input through the computer interface to dynamically program between 
various magnetic field profiles. The current setting is first regulated using a digital-to-analog 
converter. The analog signal is then buffered to a current source with a maximum swing of 2 A, 
implemented using an integrated circuit operational amplifier connected in a feedback 
configuration via a PMOS transistor to a resistive load. The DPMF array features 300 m traces 
at a pitch of 300 m.
a) 
Page 15 of 20
ACS Paragon Plus Environment
ACS Applied Bio Materials
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
b)
c)
Figure 6. Measurement setup. (a) Circuitry responsible for individually addressing each wire 
consisting of a power supply, current controller, and digital-to-analog converter. (b) Cell box 
apparatus seated in inverted microscope. (c) Top view of cell box apparatus. Connectors interface 
directly to controller circuitry. 
Next, the controller system interfaces with the second system, a cell box. The cell box 
design was previously described.17, 26 The disposable cell box was printed using a Replicator 2 3D 
printer (Makerbot, USA) and is meant to interface the DPMF device with the microscope to enable 
live cell imaging of cell movement. To promote cell viability, it features an inlet port and 
distribution channels that interface with the microscope’s incubation system to evenly distribute 
humidified CO2 atmosphere in the petri dish. A pressure relief port prevents the accumulation of 
pressure and ensures a continuous flow of atmosphere. To reduce heating of the active area, a 
copper heatsink is placed on the current grid. A thin (25.4 mm × 25.4 mm × 0.1 mm) diamond 
sliver is placed between the heatsink along with thermal paste to help distribute heat to the 
heatsink.
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Cell Speed Tracking
In order to track the cells and analyze their trajectories quantitatively, the videos 
demonstrating cell aggregation were analyzed using the TrackMate add-on in the image processing 
program ImageJ (Figure 5a-c). The speeds of the cells can be seen for each cell type (Figure 5d-
e). A number of cells started from rest, as can be seen by some of the slower speed data points far 
away from the aggregation center. Due to crowding near the aggregation center, many cells 
stopped moving near 50 µm and were no longer successfully tracked at distances less than 50 µm. 
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SUPPORTING INFORMATION
Supplementary Figure 1 contains additional TEM images of loaded cells. Video 1 shows a 
positive control for movement of magnetic particles. Videos of cell aggregation are included for 
each of the cell types: neural stem cells (Video 2), THP-1 monocytes (Video 3), and CAR T-cells 
(Video 4). Video 5 shows a negative control for non-magnetic movement of cells related to the 
experimental setup. In this video, loaded CAR T-cells are used. These materials are available free 
of charge via the Internet at http://pubs.acs.org. 
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